|
|
|
 |
|
|
 |
|
|
| |
 |
| |
 |
| |
| |
 |
| Solstice Neurosciences, Inc. |
OBP IV |
Malvern, PA and South San Francisco, CA
www.solsticeneuro.com
Solstice Neurosciences is a specialty biopharmaceutical company focused on the neurology market. Solstice's first product, Myobloc (Botulinum Toxin Type B), is currently approved in the USA and Europe for use in cervical dystonia.
|
|
| |
|
|
|
|
|
